 | | | | Latvia announced a COVID-19 lockdown from Oct. 21 until Nov. 15 to try to slow a spike in infections in one of the least vaccinated European Union countries. | | | | | | President Joe Biden's administration on Monday asked the U.S. Supreme Court to block a Texas law that imposes a near-total ban on abortion, calling the Republican-backed measure plainly unconstitutional and specifically designed to evade judicial scrutiny. | | | | | | Burundi on Monday rolled out its first COVID-19 vaccines, months after most African countries, the latest step in the East African nation's shift towards a more active approach to containing the pandemic. | | | | | | Britain reported the highest number of new COVID-19 cases in three months on Monday as the number of infections reached levels last seen when lockdown restrictions were in place in England during the summer. | | | | | | Europe's drug regulator said on Monday it has approved two more manufacturing sites for producing the COVID-19 vaccine developed by Pfizer Inc | | | | | | Europe's drug regulator said on Monday it was evaluating use of the Pfizer-BioNTech , COVID-19 vaccine in children as young as five, while also taking steps to aid an increase in production and boost the shot's reach. | | | | | | South Africa's drugs regulator said on Monday that it was not approving an emergency use application for Russia's Sputnik V COVID-19 shot for now, citing concerns about its safety for people at risk of HIV. | | | | | | The World Health Organization on Monday asked for further data from India's Bharat Biotech to consider the company's request for an emergency-use listing for its COVID-19 shot, saying the WHO could not "cut corners" in making a decision. | | | | | | The U.S. Food and Drug Administration declined to approve United Therapeutics and MannKind Corp's lung disease therapy, citing an inspection issue at a third-party facility, the companies said on Monday. | | | | | | Oyster Point Pharma Inc's treatment for dry eye disease became the first U.S. approved nasal spray for the chronic condition, sending the drug developer's shares about 7% higher in morning trade. | | | | | |
